tradingkey.logo

Bio Rad Laboratories Inc

BIO
319.550USD
+15.080+4.95%
收盘 10/31, 16:00美东报价延迟15分钟
8.62B总市值
亏损市盈率 TTM

Bio Rad Laboratories Inc

319.550
+15.080+4.95%

关于 Bio Rad Laboratories Inc 公司

Bio-Rad Laboratories, Inc. 致力于为生命科学研究和临床诊断市场开发、制造和营销一系列产品。该公司提供一系列产品和系统,用于分离复杂的化学和生物材料并识别、分析和纯化其成分。该公司通过两个部门运营:生命科学和临床诊断。生命科学部门开发、制造和营销用于生物研究、生物制药生产过程、食品检测制度和科学教育的仪器、系统、试剂和消耗品。其临床诊断部门设计、制造、营销和支持测试系统、信息系统、测试套件和专门的质量控制,为全球诊断市场的临床实验室提供服务。这些产品销往医院实验室、诊断参考实验室、输血实验室和医生办公室实验室。

Bio Rad Laboratories Inc简介

公司代码BIO
公司名称Bio Rad Laboratories Inc
上市日期Mar 17, 1980
CEOMr. Norman D. Schwartz
员工数量7700
证券类型Ordinary Share
年结日Mar 17
公司地址1000 Alfred Nobel Dr
城市HERCULES
上市交易所NYSE Consolidated
国家United States of America
邮编94547
电话15107247000
网址https://www.bio-rad.com/
公司代码BIO
上市日期Mar 17, 1980
CEOMr. Norman D. Schwartz

Bio Rad Laboratories Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Norman D. Schwartz
Mr. Norman D. Schwartz
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.39M
+214.86%
Ms. Colleen Corey
Ms. Colleen Corey
Executive Vice President, Global Human Resources
Executive Vice President, Global Human Resources
19.55K
+5.80%
Mr. Sedat Evran
Mr. Sedat Evran
Executive Vice President - Global Supply Chain
Executive Vice President - Global Supply Chain
2.02K
+53.88%
Mr. Jonathan P. (Jon) Divincenzo
Mr. Jonathan P. (Jon) Divincenzo
President, Chief Operating Officer
President, Chief Operating Officer
919.00
--
Ms. Eva Anette Engelhardt
Ms. Eva Anette Engelhardt
Executive Vice President, President of Clinical Diagnostics Group
Executive Vice President, President of Clinical Diagnostics Group
896.00
+470.70%
Mr. Gregory K. (Greg) Hinckley, CPA
Mr. Gregory K. (Greg) Hinckley, CPA
Lead Independent Director
Lead Independent Director
808.00
+61.60%
Ms. Courtney C Enloe
Ms. Courtney C Enloe
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
612.00
+414.29%
Mr. Arnold A. Pinkston
Mr. Arnold A. Pinkston
Independent Director
Independent Director
308.00
--
Mr. Jeffrey L. (Jeff) Edwards
Mr. Jeffrey L. (Jeff) Edwards
Independent Director
Independent Director
308.00
--
Ms. Melinda Litherland
Ms. Melinda Litherland
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Norman D. Schwartz
Mr. Norman D. Schwartz
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.39M
+214.86%
Ms. Colleen Corey
Ms. Colleen Corey
Executive Vice President, Global Human Resources
Executive Vice President, Global Human Resources
19.55K
+5.80%
Mr. Sedat Evran
Mr. Sedat Evran
Executive Vice President - Global Supply Chain
Executive Vice President - Global Supply Chain
2.02K
+53.88%
Mr. Jonathan P. (Jon) Divincenzo
Mr. Jonathan P. (Jon) Divincenzo
President, Chief Operating Officer
President, Chief Operating Officer
919.00
--
Ms. Eva Anette Engelhardt
Ms. Eva Anette Engelhardt
Executive Vice President, President of Clinical Diagnostics Group
Executive Vice President, President of Clinical Diagnostics Group
896.00
+470.70%
Mr. Gregory K. (Greg) Hinckley, CPA
Mr. Gregory K. (Greg) Hinckley, CPA
Lead Independent Director
Lead Independent Director
808.00
+61.60%

收入明细

单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
暂无数据
地区USD
名称
营收
占比
United States
266.90M
40.96%
Europe
217.20M
33.33%
APAC
126.40M
19.40%
Other
41.10M
6.31%
业务
地区
暂无数据

股东统计

更新时间: 10月30日 周四
更新时间: 10月30日 周四
持股股东
股东类型
持股股东
持股股东
占比
First Eagle Investment Management, L.L.C.
11.49%
The Vanguard Group, Inc.
8.41%
Alice N. Schwartz Revocable Trust
8.13%
BlackRock Institutional Trust Company, N.A.
7.05%
Schwartz (Norman D)
6.36%
其他
58.55%
持股股东
持股股东
占比
First Eagle Investment Management, L.L.C.
11.49%
The Vanguard Group, Inc.
8.41%
Alice N. Schwartz Revocable Trust
8.13%
BlackRock Institutional Trust Company, N.A.
7.05%
Schwartz (Norman D)
6.36%
其他
58.55%
股东类型
持股股东
占比
Investment Advisor/Hedge Fund
42.47%
Investment Advisor
38.94%
Individual Investor
8.27%
Corporation
8.13%
Hedge Fund
7.04%
Research Firm
1.67%
Pension Fund
1.24%
Bank and Trust
0.83%
Sovereign Wealth Fund
0.63%

机构持股

更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
1080
20.35M
92.90%
-2.73M
2025Q2
1116
24.14M
109.77%
-3.54M
2025Q1
1170
23.54M
106.01%
-2.87M
2024Q4
1159
23.02M
100.37%
-3.90M
2024Q3
1144
23.65M
103.58%
-2.77M
2024Q2
1163
23.92M
102.32%
-878.39K
2024Q1
1175
22.36M
95.71%
-2.57M
2023Q4
1205
22.70M
94.11%
-2.35M
2023Q3
1189
22.91M
95.16%
-1.86M
2023Q2
1192
23.05M
93.93%
-1.30M
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
First Eagle Investment Management, L.L.C.
2.52M
11.45%
+223.05K
+9.72%
Jun 30, 2025
The Vanguard Group, Inc.
1.84M
8.38%
-59.61K
-3.13%
Jun 30, 2025
Alice N. Schwartz Revocable Trust
1.78M
8.1%
--
--
May 01, 2025
BlackRock Institutional Trust Company, N.A.
1.54M
7.02%
-98.58K
-6.00%
Jun 30, 2025
Schwartz (Norman D)
447.98K
2.04%
+5.20K
+1.17%
Sep 06, 2025
Dimensional Fund Advisors, L.P.
999.57K
4.55%
+122.53K
+13.97%
Jun 30, 2025
Veritas Asset Management LLP
863.14K
3.92%
-49.98K
-5.47%
Jun 30, 2025
Ariel Investments, LLC
818.62K
3.72%
+93.96K
+12.97%
Jun 30, 2025
EARNEST Partners, LLC
605.89K
2.75%
+6.26K
+1.04%
Jun 30, 2025
State Street Investment Management (US)
584.37K
2.66%
-110.15K
-15.86%
Jun 30, 2025
查看更多

持股ETF

更新时间: 7 小时前
更新时间: 7 小时前
机构名称
占比
Parnassus Value Select ETF
3.15%
First Trust Indxx Medical Devices ETF
2.2%
ROBO Global Healthcare Technology & Innovation ETF
1.46%
Schwab Ariel Opportunities ETF
1.25%
FPA Global Equity ETF
1.21%
First Eagle Global Equity ETF
1.08%
Pacer US Export Leaders ETF
1.01%
WisdomTree BioRevolution Fund
0.85%
iShares Health Innovation Active ETF
0.84%
Harbor Health Care ETF
0.75%
查看更多
Parnassus Value Select ETF
占比3.15%
First Trust Indxx Medical Devices ETF
占比2.2%
ROBO Global Healthcare Technology & Innovation ETF
占比1.46%
Schwab Ariel Opportunities ETF
占比1.25%
FPA Global Equity ETF
占比1.21%
First Eagle Global Equity ETF
占比1.08%
Pacer US Export Leaders ETF
占比1.01%
WisdomTree BioRevolution Fund
占比0.85%
iShares Health Innovation Active ETF
占比0.84%
Harbor Health Care ETF
占比0.75%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
KeyAI